Skip to main content
Fig. 7 | Molecular Medicine

Fig. 7

From: HOXA1 participates in VSMC-to-macrophage-like cell transformation via regulation of NF-κB p65 and KLF4: a potential mechanism of atherosclerosis pathogenesis

Fig. 7

Silencing of HOXA1 suppresses lipid accumulation, VSMC-to-macrophage transdifferentiation, and inflammation of POV-PC treated VSMCs. POV-PC treated VSMCs were applied as in vitro model of AS. Loss-of-function investigation was performed by transduction of AAV1-shNC, AAV1-shHOXA1-1 or AAV1-shHOXA1-2. A Oil-red O staining for lipids in POV-PC treated VSMCs. B Flow cytometry analysis and quantification for CD68+ cells. C Real-time qPCR assay for MAC2, MAC3, ABCA1, ACTA2, MYH11 and CNN1 expression. D ELISA for TNF-α and MMP-2 levels. Data are expressed as mean ± SD (n = 3). Ordinary one-way ANOVA followed by Tukey's multiple comparison test was used to calculate the P value in panel B–D. **P < 0.01, ***P < 0.001

Back to article page

Molecular Medicine

ISSN: 1528-3658